Chris was previously an MD/PhD (MSTP) candidate at the University of Pennsylvania, where he completed his PhD in 2013 studying the chemical diversity of the genome. During his PhD studies, he was inspired by a clinical case which demonstrated that research for rare diseases can yield discoveries with broad impact. As Director of Clinical Research for the CDCN, Chris is passionate about accelerating research that addresses the causes of and treatments for idiopathic Multicentric Castleman Disease.